Successful treatment with sorafenib for sunitinib-refractory metastatic papillary renal cell carcinoma: Potential impact of Raf overexpression on predicting the efficacy of sorafenib.
Ryota MorinagaTakashi KawaharaJun-Ichi TeranishiMakoto ChumaKoji IzumiYasuhide MiyoshiMasahiro YaoMasako OtaniHiroshi MiyamotoHiroji UemuraPublished in: IJU case reports (2018)
As sorafenib blocks Raf signaling, the expression of Raf may serve as a useful predictor of the efficacy of sorafenib.